New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Teva Pharmaceutical Industries Limited
TEVA
Shape
US Flag

NYSE

21B

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

21B

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

18.15USD
Shape0.91Ā ( 5.28%)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

-7%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

5%

Quote Panel

Shape
Updated October 16, 2024
1W 4.25 % 1M 1.68 % 3M 10.81 % 1Y 109.58 %

Key Metrics

Shape
  • Market Cap

    20.56B


  • Shares Outstanding

    1.13B


  • Share in Float

    1.13B


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    18.15


  • Average Volume

    7.85M


  • Beta

    0.879


  • Range

    8.06-19.08


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.tevapharm.com


  • Sector

    Healthcare


Fundamentals

Shape

6.75x

P/E Ratio

1.26x

P/S Ratio

3.23x

P/B Ratio

2.9

Debt/Equity

-2.9%

Net Margin

$-0.4

EPS

How TEVA compares to sector?

P/E Ratio

Relative Strength

Shape

TEVA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$17B

Shape306%

2025-Revenue

$1.06

Shape241%

2025-EPS

$4B

Shape308%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

upgrade

Previous: Underweight

2024-02-12

Now: Overweight

Jefferies

upgrade

Previous: Positive

2024-01-23

Now: Buy

UBS

upgrade

Previous: Neutral

2023-11-27

Now: Buy

Evercore ISI

upgrade

Previous: Not converted

2023-05-18

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

0.59
vsĀ 0.59

Q4.22

arrow
arrow

-8%

0.71
vsĀ 0.77

Q1.23

arrow
arrow

-27%

0.4
vsĀ 0.55

Q2.23

arrow
arrow

-18%

0.56
vsĀ 0.68

Q3.23

arrow
arrow

+2%

0.6
vsĀ 0.59

Q4.23

arrow
arrow

+41%

1
vsĀ 0.71

Q1.24

arrow
arrow

+20%

0.48
vsĀ 0.4

Q2.24

arrow
arrow

+9%

0.61
vsĀ 0.56

Q3.24

arrow
arrow

+9%

0.66
vsĀ 0.6

Q4.24

arrow
arrow

-29%

0.71
vsĀ 1

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-7%

3.6BĀ  vsĀ 3.9B

Q4.22

arrow
arrow

-5%

3.9BĀ  vsĀ 4.1B

Q1.23

arrow
arrow

NA

3.7BĀ  vsĀ 3.7B

Q2.23

arrow
arrow

+2%

3.9BĀ  vsĀ 3.8B

Q3.23

arrow
arrow

+7%

3.9BĀ  vsĀ 3.6B

Q4.23

arrow
arrow

+15%

4.5BĀ  vsĀ 3.9B

Q1.24

arrow
arrow

+5%

3.8BĀ  vsĀ 3.7B

Q2.24

arrow
arrow

+7%

4.2BĀ  vsĀ 3.9B

Q3.24

arrow
arrow

+7%

4.1BĀ  vsĀ 3.9B

Q4.24

arrow
arrow

-7%

4.1BĀ  vsĀ 4.5B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vsĀ -0.03

Q4.22

arrow
arrow

-15%

-0.15
vsĀ 0.01

Q1.23

arrow
arrow

-3%

-0.03
vsĀ -0.15

Q2.23

arrow
arrow

-12%

-0.12
vsĀ -0.03

Q3.23

arrow
arrow

+1%

0.01
vsĀ -0.12

Q4.23

arrow
arrow

+6%

0.06
vsĀ 0.01

Q1.24

arrow
arrow

-2%

-0.02
vsĀ 0.06

Q2.24

arrow
arrow

-13%

-0.13
vsĀ -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

460

460
vsĀ 493

-7%

Q4.22

arrow
arrow

459

459
vsĀ 460

0%

Q1.23

arrow
arrow

470

470
vsĀ 459

2%

Q2.23

arrow
arrow

464

464
vsĀ 470

-1%

Q3.23

arrow
arrow

466

466
vsĀ 464

0%

Q4.23

arrow
arrow

478

478
vsĀ 466

3%

Q1.24

arrow
arrow

510

510
vsĀ 478

7%

Q2.24

arrow
arrow

557

557
vsĀ 510

9%

Earnings Growth

Latest News